Global Microneedle Flu Vaccine Market Research Report 2021

1 Microneedle Flu Vaccine Market Overview

• 1.1 Product Overview and Scope of Microneedle Flu Vaccine
• 1.2 Microneedle Flu Vaccine Segment by Type
  • 1.2.1 Global Microneedle Flu Vaccine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Solid Microneedle
  • 1.2.3 Hollow Microneedle
  • 1.2.4 Coated Microneedle
  • 1.2.5 Dissolving Microneedle
• 1.3 Microneedle Flu Vaccine Segment by Application
  • 1.3.1 Global Microneedle Flu Vaccine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Influenza A
  • 1.3.3 Influenza B
• 1.4 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Microneedle Flu Vaccine Revenue 2016-2027
  • 1.4.2 Global Microneedle Flu Vaccine Sales 2016-2027
  • 1.4.3 Microneedle Flu Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Microneedle Flu Vaccine Market Competition by Manufacturers

• 2.1 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Microneedle Flu Vaccine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Microneedle Flu Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Microneedle Flu Vaccine Market Competitive Situation and Trends
  • 2.5.1 Microneedle Flu Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
  • 2.5.3 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Microneedle Flu Vaccine Retrospective Market Scenario by Region

• 3.1 Global Microneedle Flu Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Microneedle Flu Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Microneedle Flu Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Microneedle Flu Vaccine Sales by Country
  • 3.3.2 North America Microneedle Flu Vaccine Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Microneedle Flu Vaccine Sales by Country
  • 3.4.2 Europe Microneedle Flu Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Microneedle Flu Vaccine Sales by Region
  • 3.5.2 Asia Pacific Microneedle Flu Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Microneedle Flu Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Microneedle Flu Vaccine Sales by Country
  • 3.6.2 Latin America Microneedle Flu Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Microneedle Flu Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Microneedle Flu Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Microneedle Flu Vaccine Historic Market Analysis by Type

• 4.1 Global Microneedle Flu Vaccine Sales Market Share by Type (2016-2021)
• 4.2 Global Microneedle Flu Vaccine Revenue Market Share by Type (2016-2021)
• 4.3 Global Microneedle Flu Vaccine Price by Type (2016-2021)

5 Global Microneedle Flu Vaccine Historic Market Analysis by Application

• 5.1 Global Microneedle Flu Vaccine Sales Market Share by Application (2016-2021)
• 5.2 Global Microneedle Flu Vaccine Revenue Market Share by Application (2016-2021)
• 5.3 Global Microneedle Flu Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Sanofi
  • 6.1.1 Sanofi Corporation Information
  • 6.1.2 Sanofi Description and Business Overview
  • 6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
  • 6.1.5 Sanofi Recent Developments/Updates
• 6.2 GC Pharma
  • 6.2.1 GC Pharma Corporation Information
  • 6.2.2 GC Pharma Description and Business Overview
  • 6.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
  • 6.2.5 GC Pharma Recent Developments/Updates
• 6.3 Debiotech
  • 6.3.1 Debiotech Corporation Information
  • 6.3.2 Debiotech Description and Business Overview
  • 6.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Debiotech Microneedle Flu Vaccine Product Portfolio
  • 6.3.5 Debiotech Recent Developments/Updates
• 6.4 NanoPass Technologies
  • 6.4.1 NanoPass Technologies Corporation Information
  • 6.4.2 NanoPass Technologies Description and Business Overview
  • 6.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
  • 6.4.5 NanoPass Technologies Recent Developments/Updates
• 6.5 Corium International
  • 6.5.1 Corium International Corporation Information
  • 6.5.2 Corium International Description and Business Overview
  • 6.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Corium International Microneedle Flu Vaccine Product Portfolio
  • 6.5.5 Corium International Recent Developments/Updates
• 6.6 Becton Dickinson and Company
  • 6.6.1 Becton Dickinson and Company Corporation Information
  • 6.6.2 Becton Dickinson and Company Description and Business Overview
  • 6.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
  • 6.6.5 Becton Dickinson and Company Recent Developments/Updates
• 6.7 FluGen
  • 6.6.1 FluGen Corporation Information
  • 6.6.2 FluGen Description and Business Overview
  • 6.6.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 FluGen Microneedle Flu Vaccine Product Portfolio
  • 6.7.5 FluGen Recent Developments/Updates
• 6.8 CosMED Pharmaceuticals
  • 6.8.1 CosMED Pharmaceuticals Corporation Information
  • 6.8.2 CosMED Pharmaceuticals Description and Business Overview
  • 6.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
  • 6.8.5 CosMED Pharmaceuticals Recent Developments/Updates
• 6.9 Microdermics and OraSure Technologies
  • 6.9.1 Microdermics and OraSure Technologies Corporation Information
  • 6.9.2 Microdermics and OraSure Technologies Description and Business Overview
  • 6.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
  • 6.9.5 Microdermics and OraSure Technologies Recent Developments/Updates

7 Microneedle Flu Vaccine Manufacturing Cost Analysis

• 7.1 Microneedle Flu Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Microneedle Flu Vaccine
• 7.4 Microneedle Flu Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Microneedle Flu Vaccine Distributors List
• 8.3 Microneedle Flu Vaccine Customers

9 Microneedle Flu Vaccine Market Dynamics

• 9.1 Microneedle Flu Vaccine Industry Trends
• 9.2 Microneedle Flu Vaccine Growth Drivers
• 9.3 Microneedle Flu Vaccine Market Challenges
• 9.4 Microneedle Flu Vaccine Market Restraints

10 Global Market Forecast

• 10.1 Microneedle Flu Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Microneedle Flu Vaccine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Type (2022-2027)
• 10.2 Microneedle Flu Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Microneedle Flu Vaccine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Application (2022-2027)
• 10.3 Microneedle Flu Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Microneedle Flu Vaccine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Microneedle Flu Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List